Clinical trial
Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With…
NCT00493350 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00493350 |
|---|---|
| Title | Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast Cancer |
| Official title | International Stage IV Stratification Study (ISSS): Prospective Validation Trial of Circulating Tumor Cells (CTCs) as Prognostic and Predictive Markers in Women With Metastatic Breast Cancer About to Start First-Line Treatment |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Janssen Diagnostics, LLC Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer |
| Intervention type | Procedure |
| Interventions | Blood Sample |
| Enrollment | 660 |
| Start date | Oct 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jun 28, 2007 |
| Last update posted | Jul 31, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: